Partnered onApproved Therapies
6
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
7
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Contracted with
4,000+
Investigator SitesEnrolled
43,000+
Patients1,003Clinical Projects across40Countries
Optimapharm is dedicated to helping innovative therapies reach patients, delivering over 1000 global Phase I–IV clinical projects with a strong focus on quality, service, and scientific rigour. We partner closely with small, emerging, and commercial biotech organisations, providing a high level of customer attention, responsiveness, and expert guidance throughout the development lifecycle. By combining deep clinical expertise with a service-driven approach, we help transform promising innovations into therapies that deliver real hope and meaningful outcomes for patients worldwide.
Therapeutic Expertise
Functional Capabilities
